Ochratoxin A suppresses proliferation of Sertoli and Leydig cells in mice

Keyphrases

• Sertoli Cells 100%
• Leydig Cells 100%
• Ochratoxin A 100%
• Testicular Cells 40%
• TM4 Cells 20%
• TM3 Cells 20%
• Mitochondria 10%
• Penicillium 10%
• Oncogenesis 10%
• Phosphorylation 10%
• Calcium Ion 10%
• Dose Effect 10%
• Negative Effects 10%
• ERK2 10%
• Toxic Effects 10%
• P70S6K 10%
• Hepatocytes 10%
• Spermatogenesis 10%
• Immune Cells 10%
• G1 Phase 10%
• Signaling Molecules 10%
• Antiproliferative Activity 10%
• SP600125 10%
• JNK Pathway 10%
• U0126 10%
• LY294002 10%
• AKT1 10%
• Physiological Function 10%
• Signaling Mechanism 10%
• Combination Treatment 10%
• Calcium Homeostasis 10%
• Signal Transduction Inhibitors 10%
• Biological Signals 10%
• Male Infertility 10%
• Aspergillus 10%
• Mycotoxins 10%
• Synergistic Antiproliferative Effect 10%
• Disease Pathogenesis 10%
• Mouse Sertoli Cells 10%
• Teratogenesis 10%
• Hazardous Effect 10%
• Mouse Leydig Cells 10%
• Nephron 10%
• Sperm Maturation 10%
• Abnormal Sperm 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Ochratoxin 100%
• Disease 10%
• Carcinogenesis 10%
• Toxicity 10%
• Calcium Ion 10%
• anthra[1,9 Cd]pyrazol 6(2h) One 10%
• Mitogen Activated Protein Kinase 3 10%
• Penicillium 10%
• 2 Morpholino 8 Phenylchromone 10%
• 1,4 Diamino 1,4 Bis(2 Aminophenylthio) 2,3 Dicyanobutadiene 10%
• Aspergillus 10%
• Mycotoxin 10%
• Teratogenesis 10%
• Male Infertility 10%